ACKNOWLEDGMENTS
MALARIA
We express our gratitude to the study participants. We also thank the members of the Safety Monitoring Committee (James Campbell–chair, Brian Greenwood, Mark Riddle, Alberto García-Basteiro, and Feliciano Panades Shumad–safety monitor) for their thoughtful oversight; Almudena Legarda for excellent monitoring; and the entire study team of the Equatorial Guinea Malaria Vaccine Initiative and the teams at Sanaria and Protein Potential for manufacture and shipping of investigational products (PfSPZ Vaccine, PfSPZ Challenge, diluents, and normal saline), regulatory, quality, and clinical site activities, and legal and administrative support. Trial registration: 